Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. 2003

Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
Department of Surgery, Chang Gung Memorial Hospital, 5 Fu-Hsing Street, Kwei-Shan, Taoyuan, Taiwan.

The aim of this study was to investigate the prognostic factors for hepatocellular carcinoma (HCC) in patients without cirrhosis who underwent hepatectomy. Between 1986 and 1998 a total of 197 men and 57 women with noncirrhotic HCC underwent hepatic resection in the Department of Surgery, Chang Gung Memorial Hospital, Taipei, Taiwan. We determined their surgical mortality and the disease-free and overall cumulative survival rates. The surgical mortality was 4.7% and the 5-year disease-free survival rate 24.01%. By Cox regression analysis, serum alkaline phosphatase [relative risk (RR) 1.761; 95% confidence interval (CI) 1.037-2.985)], albumin (RR 2.179; CI 1.215-3.908), multiple tumor status (RR 2.288; CI 1.272-4.115), and blood urea nitrogen (RR 4.651; CI 1.116-19.38) were shown to be independent prognostic factors for the 5-year disease-free survival rates. The 5-year overall cumulative survival rate was 25.91%. By Cox regression analysis, serum albumin (RR 1.656, CI 1.005-2.730), blood transfusion (RR 2.075, CI 1.153-3.731), resection margin (RR 2.562, CI 1.436-4.572), and multiple tumors (RR 2.801, CI 1.727-4.545) were shown to be significant independent factors that influenced cumulative survival rates. Hence in patients with a noncirrhotic HCC who underwent hepatectomy the prognosis depended on preoperative hepatic function, the presence of multiple tumors, the need for blood transfusion, and the surgical resection margin.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006498 Hepatectomy Excision of all or part of the liver. (Dorland, 28th ed) Hepatectomies
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
December 2002, Journal of surgical oncology,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
April 2001, The American journal of gastroenterology,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
March 1990, Cancer,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
July 2007, Journal of the American College of Surgeons,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
January 2002, Hepato-gastroenterology,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
March 2023, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
November 2005, Journal of the American College of Surgeons,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
April 2003, Annals of surgery,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
January 2006, Hepato-gastroenterology,
Miin-Fu Chen, and Hsiu-Pei Tsai, and Long-Bin Jeng, and Wei-Chen Lee, and Chun-Nan Yeh, and Ming-Chin Yu, and Chao-Ming Hung
March 2007, ANZ journal of surgery,
Copied contents to your clipboard!